AutoGenomics Files For IPO

Carlsbad-based AutoGenomics has filed for an IPO, saying in a filing with the SEC today that the firm is looking to raise up to $86.3M on the NASDAQ. The firm said that it is looking to list on the NASDAQ Global Market as AGMX. AutoGenomics develops molecular diagnostics systems used that automates the processes of genetic testing performed by clinical laboratories. The firm's IPO is being underwritten by JPMorgan, Deutsche Bank Securities, Pacific Growth Equities, and Robert W. Baird & Co.